ASX - By Stock
|
SP1 |
Re:
ISXFEU Listing 2024
|
|
Biglobe1
|
241 |
88K |
2 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
241
|
88K
|
2
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Placement with Existing Shareholders
|
|
Biglobe1
|
17 |
6.1K |
0 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
17
|
6.1K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
ISXFEU Listing 2024
|
|
Biglobe1
|
241 |
88K |
3 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
241
|
88K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ISXFEU Listing 2024
|
|
Biglobe1
|
241 |
88K |
11 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
241
|
88K
|
11
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
Biglobe1
|
1.7K |
737K |
6 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
1.7K
|
737K
|
6
|
|
ASX - By Stock
|
COV |
Re:
Ann: Cleo Commences US Regulatory Process with FDA
|
|
Biglobe1
|
19 |
8.3K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
19
|
8.3K
|
1
|
|
ASX - By Stock
|
COV |
Re:
Ann: Cleo Commences US Regulatory Process with FDA
|
|
Biglobe1
|
19 |
8.3K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
19
|
8.3K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
The Determination
|
|
Biglobe1
|
20 |
10K |
3 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
20
|
10K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
The Determination
|
|
Biglobe1
|
20 |
10K |
6 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
20
|
10K
|
6
|
|
ASX - By Stock
|
SOR |
Re:
Tale of the Tape
|
|
Biglobe1
|
36 |
15K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
36
|
15K
|
2
|
|
ASX - By Stock
|
SOR |
Re:
Tale of the Tape
|
|
Biglobe1
|
36 |
15K |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
36
|
15K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Give Us The Good The Bad ,and The Ugly
|
|
Biglobe1
|
31 |
12K |
1 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
31
|
12K
|
1
|
|
ASX - By Stock
|
RZI |
Re:
why the dump?
|
|
Biglobe1
|
4 |
2.3K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
4
|
2.3K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Michael Keenan
|
|
Biglobe1
|
17 |
4.2K |
2 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
17
|
4.2K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Biglobe1
|
841 |
389K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
841
|
389K
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Biglobe1
|
3.5K |
1.0M |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
How do we get our money back
|
|
Biglobe1
|
549 |
199K |
2 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
549
|
199K
|
2
|
|
ASX - By Stock
|
IPG |
Re:
IPG price action
|
|
Biglobe1
|
130 |
63K |
0 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
130
|
63K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
Biglobe1
|
43 |
17K |
3 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
43
|
17K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
The Future for SP1 and ISXFEU
|
|
Biglobe1
|
409 |
229K |
0 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
409
|
229K
|
0
|
|
ASX - By Stock
|
MPL |
Re:
News: MPL Australia's Medibank says hacker group claims to have breached systems
|
|
Biglobe1
|
19 |
6.3K |
2 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
19
|
6.3K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: ASX litigation - security for costs order
|
|
Biglobe1
|
338 |
145K |
1 |
16/10/22 |
16/10/22 |
ASX - By Stock
|
338
|
145K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: ASX litigation - security for costs order
|
|
Biglobe1
|
338 |
145K |
3 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
338
|
145K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: ASX litigation - security for costs order
|
|
Biglobe1
|
338 |
145K |
3 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
338
|
145K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: ASX litigation - security for costs order
|
|
Biglobe1
|
338 |
145K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
338
|
145K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Biglobe1
|
4.4K |
2.0M |
0 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Alcidion Quarterly Results and Investor Webcast Notification
|
|
Biglobe1
|
10 |
4.2K |
3 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
10
|
4.2K
|
3
|
|
ASX - By Stock
|
RZI |
Re:
Ann: December 2021 - Key Metrics
|
|
Biglobe1
|
14 |
4.6K |
0 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
14
|
4.6K
|
0
|
|
ASX - By Stock
|
RZI |
Re:
Ann: December 2021 - Key Metrics
|
|
Biglobe1
|
14 |
4.6K |
0 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
14
|
4.6K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Managing Director Update
|
|
Biglobe1
|
341 |
106K |
3 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
341
|
106K
|
3
|
|
ASX - By Stock
|
IDT |
Re:
Ann: IDT Onshore mRNA Manufacturing ATM Outcome & StrategyUpdate
|
|
Biglobe1
|
64 |
24K |
2 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
64
|
24K
|
2
|
|
ASX - By Stock
|
HFR |
Re:
Has the launchpad finally been ignited?
|
|
Biglobe1
|
9 |
5.9K |
1 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
9
|
5.9K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Avita Medical Changes to Calendar Year Financial Reporting
|
|
Biglobe1
|
10 |
4.3K |
2 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
10
|
4.3K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Results of Meeting
|
|
Biglobe1
|
26 |
11K |
1 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
26
|
11K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Notice of date for AGM & other relevant dates
|
|
Biglobe1
|
2 |
1.1K |
1 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Chart - EMD
|
|
Biglobe1
|
90 |
26K |
4 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
90
|
26K
|
4
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Section 249D Notice - Update from the Board of Directors
|
|
Biglobe1
|
35 |
13K |
3 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
35
|
13K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Biglobe1
|
4.3K |
3.8M |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
4.3K
|
3.8M
|
2
|
|
ASX - By Stock
|
RZI |
Re:
Ann: Section 249D Notice - Update from the Board of Directors
|
|
Biglobe1
|
35 |
13K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
35
|
13K
|
1
|
|
ASX - By Stock
|
NIC |
Re:
Valuation
|
|
Biglobe1
|
275 |
87K |
0 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
275
|
87K
|
0
|
|
ASX - By Stock
|
CAN Medicine |
Re:
CANN GROUP - Probability Of Bankruptcy
|
|
Biglobe1
|
27 |
18K |
1 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
27
|
18K
|
1
|
|
ASX - By Stock
|
NXT |
Re:
What's in the News
|
|
Biglobe1
|
1.6K |
972K |
8 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
1.6K
|
972K
|
8
|
|
ASX - By Stock
|
NIC |
Re:
Engine No.1 and Exxon
|
|
Biglobe1
|
15 |
6.1K |
1 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
15
|
6.1K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ISX off-topic thread
|
|
Biglobe1
|
3.5K |
9.5M |
2 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
3.5K
|
9.5M
|
2
|
|
ASX - By Stock
|
NXT |
Re:
What's in the News
|
|
Biglobe1
|
1.6K |
972K |
8 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
1.6K
|
972K
|
8
|
|
ASX - By Stock
|
MOB |
Re:
Ann: Mobilicom Investor Webinar
|
|
Biglobe1
|
5 |
2.2K |
1 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
5
|
2.2K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
ShareClarity has valuation of 70 cents
|
|
Biglobe1
|
11 |
9.3K |
3 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
11
|
9.3K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR Clinical Trial - Melbourne
|
|
Biglobe1
|
69 |
26K |
22 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
69
|
26K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
The dusty road to a Disallowed
|
|
Biglobe1
|
12 |
6.8K |
2 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
12
|
6.8K
|
2
|
|
ASX - By Stock
|
3DA |
Re:
Ann: Extension of Closing Date for Share Purchase Plan
|
|
Biglobe1
|
22 |
7.5K |
2 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
22
|
7.5K
|
2
|
|